1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea

C22H28N8O5S — CID 46853654

IUPAC1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea
SMILESCC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCC(=O)N4CCOCC4)nn3c2)c1
InChIInChI=1S/C22H28N8O5S/c1-22(2,3)28-36(33,34)17-10-16(11-23-12-17)15-4-5-18-25-20(27-30(18)14-15)26-21(32)24-13-19(31)29-6-8-35-9-7-29/h4-5,10-12,14,28H,6-9,13H2,1-3H3,(H2,24,26,27,32)
InChIKeyYYHMQTWHCVOTAO-UHFFFAOYSA-N
MW516.58 g/mol
LogP0.85
Rot. Bonds6

About 1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea

1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea (PubChem CID 46853654) has the molecular formula C22H28N8O5S and a molecular weight of 516.58 g/mol. Its IUPAC name is 1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea.

Molecular Properties

Compound Name1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea
PubChem CID46853654
Molecular FormulaC22H28N8O5S
Molecular Weight516.58 g/mol
Exact Mass516.19
IUPAC Name1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea
SMILESCC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCC(=O)N4CCOCC4)nn3c2)c1
InChIInChI=1S/C22H28N8O5S/c1-22(2,3)28-36(33,34)17-10-16(11-23-12-17)15-4-5-18-25-20(27-30(18)14-15)26-21(32)24-13-19(31)29-6-8-35-9-7-29/h4-5,10-12,14,28H,6-9,13H2,1-3H3,(H2,24,26,27,32)
InChIKeyYYHMQTWHCVOTAO-UHFFFAOYSA-N
XLogP0.85
TPSA159.92 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds6
Heavy Atoms36
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500516.58
LogP ≤ 50.85
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Analyze 1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea?
The IUPAC name of 1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea (CID 46853654) is 1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea.
What is the SMILES notation for 1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea?
The canonical SMILES for 1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea is CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCC(=O)N4CCOCC4)nn3c2)c1.
What is the InChIKey of 1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea?
The InChIKey is YYHMQTWHCVOTAO-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H28N8O5S/c1-22(2,3)28-36(33,34)17-10-16(11-23-12-17)15-4-5-18-25-20(27-30(18)14-15)26-21(32)24-13-19(31)29-6-8-35-9-7-29/h4-5,10-12,14,28H,6-9,13H2,1-3H3,(H2,24,26,27,32).
What are the key properties of 1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea?
1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea has a molecular weight of 516.58 g/mol, XLogP of 0.85, 6 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[6-[5-(tert-butylsulfamoyl)-3-pyridinyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-yl-2-oxoethyl)urea is sourced from PubChem (CID 46853654), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).